Use of conjugate vaccines to prevent meningitis caused by Haemophilus influenzae type b or Streptococcus pneumoniae
- 1 June 1995
- journal article
- Published by Elsevier in Journal of Hospital Infection
- Vol. 30, 313-321
- https://doi.org/10.1016/0195-6701(95)90034-9
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- Efficacy of Haemophilus influenzae type b conjugate vaccine PRP-TThe Lancet, 1994
- Predicted disappearance of Haemophilus influenzae type b meningitis in NetherlandsThe Lancet, 1994
- Vaccination with Haemophilus influenzae type b meningococcal protein conjugate vaccine reduces oropharyngeal carriage of Haemophilus influenzae type b among American Indian childrenThe Pediatric Infectious Disease Journal, 1993
- Haemophilus influenzae type b carriage and immunity four years after receiving the Haemophilus influenzae oligosaccharide-CRM197 (HbOC) conjugate vaccineThe Pediatric Infectious Disease Journal, 1993
- Thymus-Independent and Thymus-Dependent Responses to Polysaccharide AntigensThe Journal of Infectious Diseases, 1992
- Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccinesThe Journal of Pediatrics, 1992
- Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61 080 childrenThe Pediatric Infectious Disease Journal, 1991
- Risk factors of invasive Haemophilus influenzae type b disease among children in FinlandThe Journal of Pediatrics, 1989
- Prevention ofHaemophilus influenzaeType b Infections in High-Risk Infants Treated with Bacterial Polysaccharide Immune GlobulinNew England Journal of Medicine, 1987
- Vaccines for the prevention of encapsulated bacterial diseases: current status, problems and prospects for the futureImmunochemistry, 1978